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Introduction: Urinary tract infection is a public health problem world-
wide. Escherichia coli, E. coli and Klebsiella spp. are among the main 
etiologic for UTI in the Gaza Strip. The growing variations in resistance 
patterns among uropathogens to antimicrobials is multifactorial and 
varies globally. It greatly reduces/limits or complicates treatment options.
Aims: To determine the pattern of antimicrobial resistance and multi-
drug resistance among uropathogens at governmental hospitals.
Methods: We analyzed the data of 11,890 urine samples processed in 
governmental hospitals in the Gaza Strip, Palestine during 2019. The 
percentage of resistance wascalculated for uropathogens, and then 
multidrug resistance was calculated according to Centers for Disease 
Control and Prevention “CDC” definition.
Results: Of 11,890 urine samples, 2910 (24.5%) showed significant 
growth. Escherichia coliwas most frequently isolated (1743; 59.9%), 
followed by Klebsiella spp. (725; 24.9%), Pseudomonas spp. (123; 
4.2%), Streptococcus spp. (98; 3.4%), Staphylococcus aureus (41; 
1.4%). Microorganisms’ resistance was high against ampicillin (92.4%) 
and amoxicillin (91.1%), trimethoprim/sulfamethoxazole (68.2%), ce-
falexin (64.9%), doxycycline (61.9%), nalidixic acid (53.6%), cefuroxi-
me (53.0%), ceftriaxone (48.9%), ceftazidime (43.1%), ciprofloxacin 
(36.9%), gentamicin (25.8%), amikacin (3.2%). The resistance of mi-
croorganisms in males is higher than females. Multidrug resistance 
was detected in 37% of E. coli and 53% in Klebsiella spp.
Conclusion: Resistance is high and variable among uropathogens iso-
lated from patients in the Gaza strip. Both age and gender are risk 
factors in both infection and resistance pattern. The multidrug resis-
tance percentage is growing remarkably in the Gaza Strip.
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Introduction
Urinary tract infection (UTI) is a public health pro-
blem, in both community and hospitals. It is more 
prevalent in women than men [1]. According to the 
American college of obstetricians and gynecolo-
gists, about 50-60% of the women suffer from an 
episode of UTI at least once during their lifetime 
[2]. Unmanaged UTI may results in a wide range of 
serious complications starting from kidney damage, 
renal scarring and my ends with renal failure. In 
men, UTI become increasingly frequent with age 
and functional disability, but bacteriuria in elderly 
men tends to be intermittent, episodic, and more 
complex to be diagnosed [3]. 
Gram-negative bacteria are the most common 
causative agents of UTI, including E. coli, Klebsiella 
spp., and Proteus spp. While Gram-positive bacteria 
constitutes the minority of UTI infectious patho-
gens like Staphylococcus saprophyticus, Enterococci 
spp., and Streptococcus spp. [4, 5]. Antimicrobial 
resistance is becoming a major concern not only 
in nosocomial complicated UTI, but also in uncom-
plicated community-acquired UTI [6]. Concurrent 
resistance to antimicrobials of different structural 
classes has arisen in several of bacterial species and 
may complicate the therapeutic management of in-
fections, including those of the urinary tract [7]. 
Multiple drug resistance (MDR) rate for 3 and more 
drugs is arising in E. coli isolates and often com-
plicate therapeutic management of urinary tract 
infection (UTI) by this organism [7]. The extent of 
the problem in low-and middle-income countries is 
unknown because of the scarcity of data, but high 
levels of resistance are increasingly being reported 
worldwide [8]. 
In Palestine, antimicrobials are poorly regulated 
and available on the private market and can be 
accessed with or without a prescription [9]. Gaza 
Strip is one of the high-density populated area, in 
which governmental hospitals is the back bone of 
UTI infections treatment. In this study, the common 
uroptahogens were determined and the pattern of 
resistance of E. coli and Klebsiella spp. were detec-
ted and the MDR rates were determined. 
Methods and materials
Study design and settings
This is a retrospective study in design that was con-
ducted in four governmental hospitals (European, 
Al Shifa, Nassr, and Al Durra Hospitals) in Gaza 
Strip, Palestine over a period one year (1/1/2019 to 
31/12/2019). 
Data collection
The study data were collected from urine culture 
records of samples that were sent to the Microbio-
logy laboratory during the study period. All samples 
diagnosed with UTI infection by physicians in hos-
pital were included. An approval from the Helsinki 
Ethical Committee was obtained before the study 
and a permission from the Ministry of Health was 
granted to use the data.
The records of 11,890 urine samples results were 
studied. According to the microbiology lab Stan-
dard Operation Procedure, midstream urine samples 
were collected in sterile containers and cultured on 
blood agar and MacConkey media with a standard 
calibrated loop and were incubated at 37°C over-
night. A growth of ≥ 105 colony-forming units/
mL was considered as significant bacteriuria. The 
identification of isolates was done through Gram-
staining and conventional biochemical methods. 
Antimicrobial susceptibility was done by Kirby–Bauer 
disc diffusion method on Mueller–Hinton agar and 
the interpretations were carried out according to the 
Clinical and Laboratory Standards Institute guidelines 
[10]. Antibiotic disks used in the susceptibility testing 
varied according to their availability. Data were ob-
tained in the form of Microsoft excel file containing 
all the recorded cases UTI cultures results contains 
susceptibility, resistance to the used antimicrobials, 
name of the uropathogen, age, gender, date of test, 
area of living, name of hospital, and diagnosis at the 
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four governmental hospitals, the data cleaned, coded 
and exported to SPSS to be analyzed.
Data analysis 
Data analysis was done, using SPSS 22 (2019). 
Cross tabulation was made; to detect any corre-
lations, and/or differences among the investigated 
variables, using chi square, and independent T test. 
P-value equal or less than 0.05 was considered sta-
tistically significant, with confidence interval (CI) of 
95%. Tables, histograms, and charts were used to 
present the data. Indicators which used in the study 
designed to reflect antimicrobial susceptibility situa-
tion in governmental hospitals. 
Results
Distribution frequency of uropathogens 
Only 2,910 (24.5%) exhibited significant growth and 
were considered as positive for UTI. Among the uro-
pathogens isolated during the data collection period, 
E. coli constituted the majority with 59.9%, followed 
by Klebsiella spp. (24.9%), Pseudomonas spp. (4.2%), 
and Proteus spp. (2.4%). Gram-negative bacteria 
constituted 91% of the isolates, while Gram-positive 
(S. aureus, Enterococcus spp., and Streptococcus 
spp.) represented in less than 5.5%.In addition, less 
than 3% of the isolates were classified as "others" 
as shown in Table 1. 
Prevalence of UTI according to patients’ 
gender
Females represented 71.4% of all positive urine cul-
tures with an odds ratio of 1.863 (Table 2).
The antibiogram of uropathogens 
recovered from patient samples 
Table 1 demonstrates that E. coli and Klebsiella spp. 
constitutes about 85% of the total isolates, which 
means that they are the main etiologic agents of 
UTI, therefore, the study will focus on these isolates 
as the main findings. Aprominent finding is the high 
resistance exhibited by uropathogens to penicillin 
group. The resistance to penicillin derivatives like 
ampicillin was 91% and amoxicillin was 90%, for 
E. coli, and the resistance is 95% for Klebsiella spp. 
to the same antimicrobials Table 3. As shown in Ta-
ble 3 E. coli is highly resistant to the cephalosporin 
group. Its resistance ranges from 41% to 60% aga-
inst all of the cephalosporins. E. coli has the highest 
resistance against cephalexin (60%) and the lowest 
resistance against ceftazidime (41%). Klebsiella spp. 
has resistance (73%) and (49%) against the same 
antimicrobials, respectively. Also, Table 3 shows that 
the antibiotic resistance patterns of E. coli to the 
listed tested antibiotics. 
Table 2.  Frequency of gender distribution of UTI ca-
ses from the four governmental hospitals 







Table 1.  The distribution frequency of uropathogens 
isolates at the four governmental hospitals.
Organism isolated 
n=2,910 Total
Frequency % N %
Gram negative 
Escherichia coli 1,743 59.9
2672 91.8
Klebsiella spp. 725 24.9
Proteus spp. 69 2.4
Enterobacter spp. 12 0.4
Pseudomonas spp. 123 4.2
Gram positive
Staphylococcus aureus 41 1.4
152 5.25Enterococcus spp. 13 0.4
Streptococcus spp. 98 3.4
Others 
Candida spp. 70 2.4
86 2.95
Others 16 0.5
Total 2,910 100 2,910 100
The InTernaTIonal arabIc Journal of anTImIcrobIal agenTs 
ISSN: 2174-9094
2021
Vol. 11 No. 1:4
doi: 10.3823/855
This article is available at: www.intarchmed.com 4
Table 3.  Resistance pattern of uropathogens to antimicrobials at the four governmental hospitals in the Gaza Strip/Palestine during.
Antimicrobial
Disk charge E.  coli Klebsiella spp. Proteus spp. Enterobacter spp. Pseudomonas spp. S. aureus Enterococci Streptococcus spp.
Microgram N % N % N % N % N % N % N % N %
Penicillin G 6 - - - - - - - - - - 3 75 4 36 1 100
Ampicillin 10 553 91 245 95 27 90 5 100 30 100 3 60 3 30 5 100
Amoxicillin 20 154 90 70 95 13 87 4 100 7 88 5 71 1 100 2 67
Cloxacillin 5 - - - - - - - - - - 5 50 - - 19 79
Piperacillin 100 148 74 90 79 2 50 1 50 19 79 - - - - - -
Cephalexin 30 540 60 279 73 21 68 2 67 42 91 2 15 4 67 29 74
Cefuroxime 30 682 49 350 62 20 37 3 33 63 81 6 26 7 64 24 47
Cefotaxime 30 474 44 267 60 10 24 - - 29  43 2 67 4 57 - -
Ceftazidime 30 494 41 243 49 18 45 1 20 36 38 1 50 7 100 - -
Ceftriaxone 30 681 46 364 59 16 29 2 22 49 49 3 50 5 56 - -
Cefazolin 30 344 53 154 61 10 34 4 50 32 84 3 75 1 50 - -
Doxycycline 30 304 59 151 66 16 80 0 0 41 85 4 29 - - 12 48
Amikacin 30 15 2 14 4 1 3 - - 5 8 1 17 5 63 - -
Gentamicin 30 321 23 172 29 20 38 4 40 23 24 8 30 7 54 25 48
Co-Trimoxazole 1.25/23.75 959 66 420 69 47 80 8 80 78 91 14 54 4 67 46 78
Nalidixic acid 30 852 53 330 50 37 63 3 30 87 84 1 33 5 100 4 100
Ciprofloxacin 5 450 35 198 38 16 34 4 40 36 36 12 38 7 70 45 63
Rifampicin 5 - - 1 50 - - - - - - 1 3 - - 27 36
Vancomycin 30 - - - - - - - - - - 8 21 2 18 17 18
Co-amoxiclav 20/10 45 73 17 68 5 63 - - 3 75 13 45 1 50 32 42
Meropenem 10 24 6 16 8 3 14 1 25 11 20 0 0 1 50 - -
Nitrofurantoin 300 20 15 24 44 2 50 0 0 8 73 - - - - - -
Piperacillin + 
tazobactam
100/10 13 9 9 11 0 0 0 0 0 0 - - - - - -
Total R % 7082 45 3422 53 284 46 42 40 600 56 95 33 68 56 288 49
-: This antimicrobial did not used for this microorganism 00   This microorganism is 0% resistant to antimicrobial
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Table 4. Antimicrobial resistance of uropathogens according gender at four governmental hospitals in the Gaza Strip- Palestine during 2019.
Isolate E. coli Klebsiella spp. Pseudomonas spp. Proteus spp.
P. value
Antimicrobials
Female Male Female Male Female Male Female Male
N % N % N % N % N % N % N % N %
Ampicillin 428 90 125 94 150 94 95 97 12 100 18 100 19 86 8 100 0.164
Amoxicillin 121 90 33 89 43 93 27 96 2 67 5 100 10 83 3 100 0.087
Piperacillin 107 70 41 85 57 73 33 92 10 77 9 82 1 33 1 100 0.052
Cephalexin 388 57 152 69 177 71 102 78 19 90 23 92 10 53 11 92 0.188
Cefuroxime 483 45 199 62 219 59 131 66 28 76 35 85 10 29 10 53 0.282
Cefotaxime 333 41 141 53 165 58 102 63 14 41 15 45 6 22 4 27 0.562
Ceftazidime 330 37 164 52 158 48 85 53 17 35 19 40 12 43 6 50 0.105
Ceftriaxone 473 42 208 56 233 56 131 65 18 38 31 60 10 28 6 30 0.272
Cefazolin 248 50 96 64 97 58 57 68 14 78 18 90 6 27 4 57 0.242
Amikacin 7 1 8 4 6 3 8 6 2 8 3 8 1 4 0 0 0.832
Gentamicin 225 20 96 30 113 29 59 30 11 23 12 25 13 38 7 37 0.545
Doxycycline 206 57 98 63 113 65 38 69 19 83 22 88 12 75 4 100 0.367
Co-Trimoxazole 731 66 228 66 291 69 129 71 36 86 42 95 29 73 18 95 0.389
Nalidixic acid 608 50 244 62 226 51 104 48 43 84 44 83 24 60 13 68 0.722
Ciprofloxacin 292 30 158 48 136 38 62 38 21 40 15 31 9 30 7 41 0.299
Co-amoxiclav 35 71 10 77 15 65 2 100 2 67 1 100 3 50 2 100 0.006
Meropenem 15 6 9 8 12 9 4 7 5 17 6 23 3 20 0 0 0.572
Nitrofurantoin 15 15 5 14 13 34 11 69 1 33 7 88 2 50 0 0 0.678
Piperacillin + 
tazobactam
8 7 5 14 6 10 3 13 0 0 0 0 0 0 0 0 0.610
Total 5053 43 2020 53 2230 51 1183 57 274 54 325 60 180 44 104 59 0.024
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Antimicrobial resistance pattern of 
uropathogen according to patient's 
gender
As shown in Table 4, among males, the resistance 
of E. Coli to antimicrobials was 10-15% higher than 
among females  to the following antibiotics (pipe-
racillin, cephalexin, cefotaxime cefuroxime, cefotaxi-
me, ceftazidime, ceftriaxone cefazoline ciprofloxacin 
gentamicin, and nalidixic acid). Thetotal resistance 
of E. coli to all antimicrobials in females was 43%, 
while in males it was 53%. According to Klebsiella 
spp., among males, its resistance to the following 
antimicrobials (cephalexin, cefotaxime cefuroxime, 
cefotaxime, ceftazidime, ceftriaxone cefazoline, 
amikacin, doxycycline, ciprofloxacin gentamicin, co- 
trimoxazole, and nalidixic acid) was 3-9% higher 
than in females. The total antimicrobial resistance 
of Klebsiella among female isolates is 51% while in 
males 57%. Despite higher prevalence of UTI in the 
female than in males Table 2, the resistance percen-
tage against antimicrobial is higher in male than in 
the female. By conducting independent T-test for all 
antimicrobials, P. values is statistically significant only 
for co-amoxiclav (P. value= 0.006) and marginally 
significant for piperacillin (P. value= 0.052) and the 
total antimicrobial resistance was statistically signifi-
cant (P. value= 0.024) as shown in Table 4
Antimicrobial resistance pattern of 
uropathogens according to patient’s age 
As shown in Table 5, there was fluctuation in the 
resistance of the microorganisms against antimi-
Table 5.  Percentage of antimicrobial resistance of all microorganisms at the four governmental hospitals 
distributed by age groups in the Gaza Strip-Palestine 2019.
Antimicrobials
Age groups ANOVA Scheffe test
0-28 day 29d-1 year 1-12 y Adult
P. value P. valueR % R % R % R %
Cefuroxime 22 47 99 46 463 44 577 66 0.300 .012
Ampicillin 30 97 86 91 485 90 277 96 0.046 .010
Amoxicillin 4 80 45 92 115 91 97 90 0.162 .003
Piperacillin 0 0 22 73 91 61 149 89 0.000 .009
Cephalexin 16 53 52 60 331 54 524 75 0.052 .013
Cefotaxime 13 43 57 39 279 37 441 62 0.035 .077
Ceftazidime 12 40 39 35 201 32 554 50 0.069 .303
Ceftriaxone 13 46 92 44 353 35 667 63 0.056 .052
Cefazolin 8 42 57 53 192 44 295 69 0.008 .015
Amikacin 1 3 6 4 14 2 22 6 0.036 .416
Gentamicin 7 16 24 12 146 14 407 41 0.000 .002
Doxycycline 6 67 7 64 12 52 504 62 0.097 .274
Co-Trimoxazole 26 60 131 67 564 63 859 73 0.436 .002
Nalidixic acid 17 39 78 36 394 38 835 71 0.000 .004
Ciprofloxacin 5 16 20 15 120 15 627 55 0.000 .000
Co-amoxiclav 2 100 11 69 37 71 68 46 0.815 .134
Colistin 0 0 17 85 106 60 9 28 0.000 .870
Meropenem 1 50 1 5 0 0 56 10 0.000 .371
Nitrofurantoin 1 25 2 33 4 13 49 29 0.984 .567
Piperacillin + 
tazobactam
0 0 5 21 11 10 6 5 .011 .896
ANOVA P. value: among all age groups; Scheffe test; P. Value between 0-28 days group & adult group.
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crobials in different age groups. ANOVA test was 
used to determine the significance of this variation. 
The result of ANOVA revealed that the fluctuation 
among age categories is statistically significant for 
number of antimicrobials (ampicillin, piperacillin, ce-
fotaxime, cefazolin, amikacin, gentamicin, nalidixic 
acid, ciprofloxacin, and piperacillin + tazobactam) at 
P. value of < 0.05). Two antimicrobials (cephalexin 
and ceftriaxone) at P. value of < 0.05, while other 
antimicrobials were not statistically significant (e.g., 
cefuroxime, amoxicillin, ceftazidime, doxycycline, 
co-trimoxazole, co-amoxiclav, and nitrofurantoin). 
When Scheffe test was performed to test resistan-
ce variations among these age groups, it was found 
that there is a prominent correlation between age 
group 0-28 days and adult group with (P. value of 
less than 0.05(for cefuroxime, ampicillin, amoxicillin, 
piperacillin, cephalexin, cefazolin, gentamicin, co-tri-
moxazole, nalidixic acid, and ciprofloxacin) Table 5.
Antimicrobial resistance pattern of 
uropathogen according to both gender 
and age
E. coli isolates were grouped according to age and 
gender, the difference is high between males and 
females in the age category of (0-28 days). Within 
the age category (29 days to 1 year), the resistan-
ce in females is higher than in males for most of 
the antimicrobials. However, in the age categories 
(1 year to 12 years) and adults, the resistance is 
higher in males to most of the antimicrobials than 
in females. As shown in Figure 1, E. coli resistance 
to antimicrobials among male isolates was higher 
than females isolate in most of the age catego-
ries. In the age category (0-28 days), E. coli isolates 
were resistant to amoxicillin is closed 100% in both 
genders. There is a difference in resistance of the 
E. coli against these antimicrobials (cephalexin, ce-
ftazidime, ceftriaxone, and cefuroxime) in this age 
category about 30-40% between genders, howe-
ver, both co-trimoxazole, and nalidixic acid show 
resistance in females, is higher than males in this 
age category. Among the age category (29 days 
to 1 year), E. coli in males is more resistant than in 
female against amoxicillin, cephalexin, and cefota-
xime, while the resistance in female is higher than 
males against ceftazidime, gentamicin cephazolin, 
co-trimoxazole, nalidixic acid, and piperacillin Figu-
re 2. In the age category (1 year to 12 years), E. 
coli resistance in males is higher than in females 
against piperacillin, cephalexin, cefuroxime, cefo-
taxime, ceftazidime, cefazoline, nalidixic acid, and 
ciprofloxacin. The resistance of E. coli in female iso-
lates higher than male against amoxicillin and co-
trimoxazole. The resistance of E. coli to gentamicin 
is almost the same Figure 3.
Figure 1: E. coli resistance percentage to antibiotics in males and females (0-28 days).
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In the age category, (adults) the resistance of E. 
coli in male is higher than in female against the all of 
the antimicrobials (amoxicillin, piperacillin, cephale-
xin, cefuroxime, cefotaxime, ceftazidime, ceftriaxo-
ne, cefazolin, gentamicin, co-trimoxazole, nalidixic 
acid, ciprofloxacin) Figure 4.
Multiple drug resistance in uropathogens
Regarding to multidrug resistance definition [11], 
which is not yet agreed upon by the medical com-
munity. Many definitions are currently being used to 
characterize patterns. The most practical definition 
used for Gram-positive and Gram-negative bacteria 
is ‘resistant to a single antibiotic in three or more 
antimicrobial classes [12], these antibiotic groups 
have been chosen according to lists suggested by 
professionals for isolates have no intrinsic factors for 
resistance to these antibiotics, and according to the 
standard operating procedures SOPs that is followed 
by the laboratory technicians at the governmental 
hospital in the Gaza Strip/Palestine, these antibio-
tics are ampicillin, cefuroxime, co-trimoxazole, ci-
profloxacin, gentamicin, the isolates of E. coli and 
Klebsiella spp. as shown in Table 6, the observation 
is the resistance for a single antibiotic (ampicillin) 
from the penicillin group of E. coli is (91%) and for 
Klebsiella spp. is (91%) and by adding another an-
tibiotic (cefuroxime) from cephalosporin group the 
Figure 3: E. coli resistance percentage to antimicrobial in male female (1-12 years).
Figure 2: E. coli resistance percentage to antimicrobial in malesand females (29 days-1 year).
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resistance percentage for isolates for penicillin and 
cefuroxime for the same isolates is (45%) for E. coli 
and (58%) for Klebsiella spp., after adding the third 
antibiotic (Co-Trimethoprim) from aminoglycoside 
group the resistance for the same isolates for these 
antibiotic groups is (37%) for E. coli and (53%) for 
Klebsiella spp., after addition of the fourth antibio-
tic group fluoroquinolone (ciprofloxacin) and accor-
ding to the definition, the multidrug resistance is 
(18%) for E. coli and (31%) for Klebsiella spp., after 
addition of the fifth antibiotic group (Gentamicin) 
multidrug resistance is (11%) for E. coli and (22%) 
for Klebsiella spp., from these findings multidrug 
resistance was detected in uropathogens, (37%) for 
E. coli and (53%) for Klebsiella spp. the same isola-
tes by three different antibiotics in different groups. 
This is alarming and should be considered by any 
antibiotic stewardship programs. (Table 6)
Discussion
This study aimed to determine the resistance pat-
tern of uropathogens to antimicrobials and to ex-
plore the MDR at the governmental hospitals in 
the Gaza Strip/Palestine. Uropathogens were isola-
ted from 24.5% of the requested urine cultures. E. 
coli constituted the majority of isolates with 59.9%, 
followed by Klebsiella spp. (24.9%) and all Gram-
negative constituted 91% of the isolates. Females 
represented by 71.4% of all positive urine cultu-
res. E. coli resistance rate to penicillin derivatives 
like ampicillin was 91% and amoxicillin 90%, while 
resistance rate of Klebsiella spp. was 95% for the 
same antimicrobials. E. coli is highly resistant to the 
cephalosporin group. Its resistance is between 41% 
and 60% against all of the cephalosporines, Kleb-
siella spp. has resistance (73%) and (49%) against 
the same antimicrobials, respectively. Both of E. coli 
Figure 4: E. coli resistance percentage to antimicrobial in male and female adults.
Table 6.  Multidrug resistance percentage for uro-
pathogens the same isolates for different 
antibiotic groups at governmental hospitals 






N % N %
1 Ampicillin 553 91 245 95
2 Ampicillin + Cefuroxime 242 45 131 58
3
Ampicillin + Cefuroxime 
+ Co-Trimoxazole
162 37 90 53
4
Ampicillin + Cefuroxime 
+ Co-Trimoxazole+ 
Ciprofloxacin
55 18 33 31
5
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and Klebsiella have the minimal resistance against 
amikacin, which are (2%) and (4%), respectively. 
The resistance percentage against the tested an-
timicrobials is higher in male than in the female. 
Regarding to our study, MDR in Gaza governmental 
hospitals is (37%) for E. coli and (53%) for Klebsiella 
spp., respectively.
We demonstrated very high prevalence of Gram-
negative isolates and this in agreement with a study 
in Lahore, Pakistan conducted between December 
2018 and June 2019, which reported that preva-
lence of 92%Gram negative [13]. Another study in 
Ethiopia reveled that Gram-negative bacteria cau-
sed 90% of UTI cases while gram-positive bacteria 
cause only 10% of the cases [14]. In North Ethiopia, 
E. coli prevalence in UTI was 60.29% and Klebsiella 
spp. prevalence was 5.88% in a study conducted 
from 2002 to 2011 [15]. Another study reported 
79% E. coli prevalence in UTI in Luxembourg [16] 
which higher than our findings.
In Sarajevo, E. coli had the highest antimicrobial 
resistance to trimethoprim/sulfamethoxazole 
(38.61%), followed by amoxicillin/clavulanic acid 
(19.62%), ciprofloxacin (9.49%), genta-micin 
(8.86%), cephalexin (8.23%), nitrofurantoin 
(8.23%), cefuroxime (7.52%), ceftazidime (6.33%), 
cefuroxime (89.87%), amikacin (4.43%) [17]. These 
findings are lower than our findings. A study from 
Iraq in 2016 demonstrated resistance pattern for E. 
coli similar to this study. The resistance was 100% 
for penicillin and 52% for cephalosporin [18]. In 
Saudi Arabia, the resistance of Klebsiella spp. was 
91% against ampicillin, 57% against cefotaxime, 
and 46% against ceftazidime [19]. Another study 
from India revealed that E. coli resistance against 
amikacin was (16-38%), followed by cefotaxime 
(38-40%), gentamicin (42-68%), ciprofloxacin (54-
73%), and co-trimoxazole (74-90%) during the pe-
riod between 2000 and 2004 [20]. 
A study in Saudi Arabia found that the resistan-
ce of E. coliagainst meropenem was 7%, amikacin 
(9%) and gentamicin (18%) [19]. In south Iran, a 
study conducted in 2019 found that the resistance 
of E. coli against nalidixic acid was 71.9% [21]. In 
Rajasthan, a 2012 study recorded an overall resis-
tance of E. coli against nalidixic acid, norfloxacin, 
and ciprofloxacin as (94%), (77%), and 74.75%, 
respectively [22]. 
A retrospective study investigated 16,883 urine 
culture samples conducted in Palestine between 
2001 and 2013, demonstrated that Gram-negative 
uropathogens showed good susceptibility towards 
ciprofloxacin, ofloxacin, norfloxacin, cefuroxime, ni-
trofurantoin, sulphathiazole/trimethoprim, nalidixic 
acid, and amoxicillin/clavulanic acid, (76.1%, 71.8%, 
72.9%, 64%, 67.5%, 48.7%, 57.6%, 42.1%, res-
pectively) [23]. 
In Turkey, a retrospective study, evaluated causa-
tive agents and antimicrobial resistance in urine iso-
lates from the positive community period between 
2014 and 2016, it revealed that the resistance of E. 
coli during these years against co-trimoxazole was 
(29.8%) [24]. In addition, higher resistance rates aga-
inst ampicillin Bangladesh 2020 found (100%) [25]. 
These variations among various studies from di-
fferent countries may be due to different geogra-
phical settings, variations in use or misuse of anti-
microbials, different treatment protocols, and study 
sample size among many other causes. Resistance 
varies over time and many of the above listed stu-
dies were conducted in different settings and times.
According to 2020 CDC update, a microorganism 
protects itself from antibiotic in various ways.K. 
pneumoniae produce enzymes called carbapenems, 
which break down carbapenem drugs and most 
other beta-lactam drugs.E. coli bacteria with the 
mcr-1 gene can add a compound to the outside of 
the cell wall so that the drug colistin cannot latch 
onto it [26]. 
Several risk factors are associated with UTIs, in-
cluding gender. The shorter distance to the bladder 
in women makes it easier for bacterial colonizers 
to reach it [27]. Male patients, have a lower risk of 
contracting uncomplicated UTIs but are more prone 
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to contracting complicated or MDR infections [28]. 
Our data reflect the severe nature of UTI in men, 
in which infections are caused by MDR microorga-
nisms 
A study conducted in Pakistan in 2008 gave simi-
lar results, it reported variations among age groups 
with regard to resistance and it appeared that in the 
case of males, E. coli isolates were susceptible to ni-
trofurantoin in age groups 0+, 50+, and 70+, while 
in age groups 20+, 30+ and 60+ hundred percent 
resistance was recorded. E. coli. In females, showed 
no resistance to nitrofurantoin in age groups 10+, 
50+, and 70+, while it showed 33% resistance in 
age groups 0+, 20+, and 30+. E. coli isolates from 
age groups 50+ and 70+ both in males and females 
were found to be 100% susceptible to the nitrofu-
rantoin [29]. 
One study concluded that antibiotics that tar-
get DNA synthesis result in a progressively higher 
number of resistant isolates among the older po-
pulation. The results emphasize the importance of 
patient age on antibiotic selection as a preventive 
measure to reduce the rate of resistant infections in 
each susceptible population. This pattern suggests 
that physicians should take into consideration pa-
tient age as another factor in determining the best 
antibiotic regiment with the aim of curtailing the 
emergence of newer resistant phenotypes in the 
future [30]. 
A study in southwest Washington in 2013 showed 
statistically significant differences between males 
and females in the age-specific susceptibilities of E. 
coli to ampicillin, co-amoxiclav, ciprofloxacin, and 
nitrofurantoin. Urinary E. coli isolates from male 
patients tend to exhibit increased antimicrobial 
resistance than isolates from female patients. 
Despite the statistical significance of time trends 
and differences in age-specific susceptibilities, the 
magnitude of these differences was generally less 
than 5% and thus may not represent clinically 
meaningful differences. The exception was 
susceptibility to amoxicillin-clavulanate, where 
susceptibility was roughly 10% lower in males aging 
18 to 64 years than females in the same age group 
[31]. A 10 year study of community UTI in Portugue-
se patients also identified differences in antimicro-
bial susceptibility according to patient gender. The 
authors reported that urinary isolates of E. coli were 
significantly more resistant to fluoroquinolones, 
penicillin’s, nitrofurantoin, and first and second-
generation cephalosporins among men compared 
to women [32]. Another study focused on pediatric 
patients, also identified significantly higher resis-
tance to co-trimoxazole and ciprofloxacin in male 
versus female patients [33]. 
The NAUTICA (the North American Urinary Tract 
Infection Collaborative Alliance) surveillance study 
of outpatient UTIs, reported greater antimicrobial 
resistance to ciprofloxacin, levofloxacin, and co-tri-
moxazole among all urinary isolates from U.S. and 
Canadian male patients [34]. In the CANWARD 
(Canadian Ward) Surveillance Study, antimicrobial 
susceptibility among all E. coli isolates (not limited 
to urine isolates) collected from Canadian tertiary 
medical centers were compared and resistance 
was also observed to be significantly higher to 
ciprofloxacin, levofloxacin, and co-trimoxazole in 
isolates collected from male patients versus female 
patients [35]. 
Most studies of urinary tract infections (UTIs) fo-
cus on female patients because of the higher inci-
dence in women than in men. For this reason, most 
UTI guidelines are based on studies performed on 
women, despite the obvious genito-urinary differen-
ces [36]. In men, UTIs become increasingly frequent 
with age and functional disability, but bacteriuria in 
elderly men tends to be intermittent, episodic, and 
more complex to diagnose. It is generally recogni-
zed that treatment recommendations for women 
are not usually appropriate for men. However, gui-
delines or recommendations for the management 
of men are mostly based on studies in women, 
children and institutionalized elderly people of both 
sexes [3]. 
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A study conducted in Arabia Saudi in 2018 
showed a slightly high level of multidrug resistance 
among the tested isolates if compared with our re-
sults with (67%) of all E. coli isolates showing the 
MDR phenotype. Of these isolates, (26.86%) isolates 
were resistant to 3 antibiotic groups (25.37%) were 
resistant to 4 antibiotic groups, and (14.92%) were 
resistant to 5 antibiotic groups [37]. A study conduc-
ted in Jordan, reviled that there is high percentage 
of uropathogenic E. coli isolates from outpatients 
and hospitalized Jordanian patients in Amman area, 
is multidrug resistant to at least 3 antibiotics [38]. 
Conclusion
The main etiologic agents for UTI sare E coli and 
klebsiella spp. Penicillin is no longer be suitable 
treatment for UTI. Both age and gender are risk 
factors in both infection and resistance pattern. An-
timicrobial stewardship program should be establis-
hed under the MoH supervision, physicians should 
minimize the empirical use of antimicrobials in non-
life-threatening infection and rely more on culture 
and sensitivity for specific treatment. This type of 
study should be performed regularly to monitor the 
resistance of microorganisms to antimicrobials, not 
only for UTI but also for all types of infections for 
humans and animals as well to find the proper way 
to minimize multidrug resistance.
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